Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Trevena Inc (TRVN)

Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Trevena: Q1 Earnings Snapshot AP - Wed May 15, 6:18AM CDT

Trevena: Q1 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Trevena: Q4 Earnings Snapshot AP - Mon Apr 1, 6:13AM CDT

Trevena: Q4 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Trevena: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Trevena: Q3 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Trevena: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Trevena: Q2 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Trevena: Q1 Earnings Snapshot AP - Mon May 15, 2023

Trevena: Q1 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027 FinancialNewsMedia - Tue May 9, 2023

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

IMC.AX : 0.088 (+2.33%)
SILO : 0.9626 (+0.80%)
LLY : 914.57 (+1.83%)
ACOR : 0.6610 (-24.86%)
TRVN : 0.2167 (+4.13%)
IMRN : 2.01 (-0.50%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027 PR Newswire - Tue May 9, 2023

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

SILO : 0.9626 (+0.80%)
LLY : 914.57 (+1.83%)
ACOR : 0.6610 (-24.86%)
TRVN : 0.2167 (+4.13%)
IMRN : 2.01 (-0.50%)
Trevena (NASDAQ: TRVN) Partner Receives Approval for OLINVYK in China Spotlight Growth - Mon May 8, 2023

Trevena, Inc. (NASDAQ: TRVN) is engaged as a biopharmaceutical company, which is focused on the research, development and commercialization of

TRVN : 0.2167 (+4.13%)
Trevena: Q4 Earnings Snapshot AP - Thu Mar 30, 2023

Trevena: Q4 Earnings Snapshot

TRVN : 0.2167 (+4.13%)
Trevena: Q3 Earnings Snapshot AP - Wed Nov 9, 2022

Trevena: Q3 Earnings Snapshot

TRVN : 0.2167 (+4.13%)

Barchart Exclusives

1 ETF Set to Benefit from the Weak Japanese Yen Barchart - Sat Jul 6, 8:00AM CDT
The Japanese stock market, driven by powerful exporters like Toyota, could benefit from persistent weakness in the yen. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot